Metabolic vulnerability of cisplatin‐resistant cancers

Cisplatin is the most widely used chemotherapeutic agent, and resistance of neoplastic cells against this cytoxicant poses a major problem in clinical oncology. Here, we explored potential metabolic vulnerabilities of cisplatin‐resistant non‐small human cell lung cancer and ovarian cancer cell lines...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EMBO J
Huvudupphovsmän: Obrist, Florine, Michels, Judith, Durand, Sylvere, Chery, Alexis, Pol, Jonathan, Levesque, Sarah, Joseph, Adrien, Astesana, Valentina, Pietrocola, Federico, Wu, Gen Sheng, Castedo, Maria, Kroemer, Guido
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2018
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6043854/
https://ncbi.nlm.nih.gov/pubmed/29875130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embj.201798597
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk